Our collegue Peter Maas will be attending the international drug repurposing conference (iDR24) in Barcelona, Spain on March 6-7, 2024. In this global event, key opinion leaders from both the research and patient communities, funders, regulators and representatives from the private sector will participate to collectively advance innovative drug repurposing in Europe and beyond.
Peter will be happy to discuss with you how our experience in drug repurposing has played a pivotal role in the drug discovery process of our customers.
published on: 04-Mar-24